Fig. 2From: Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contextsRelationships of preference measurement methods. The smoothed line and increase in circle size portray the relationship between the preference measuresBack to article page